It has been known for more than 60 years, and suspected for over 100, that alveolar hypoxia
causes pulmonary vasoconstriction by means of mechanisms local to the lung. For the last …

Sarcoidosis is a multisystem granulomatous disease of unknown etiology characterized by
noncaseating granulomas in involved organs. Organs involved with sarcoidosis include …

Study objectives: The development of pulmonary arterial hypertension (PAH) can complicate
many interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF). We sought to …

Background: Pulmonary hypertension (PH) is a rare complication of sarcoidosis, although it
is not uncommon in advanced disease. Methods: A retrospective series of 22 sarcoidosis …

Objective To investigate the frequency of pulmonary hypertension (PH) and clinical
parameters associated with PH in sarcoidosis patients. Methods A prospective …

The complex nature of interactions between the pulmonary and cardiovascular systems is
becoming increasingly appreciated. Pulmonary vascular abnormalities are frequently …

Objectives: To identify factors associated with mortality in patients with sarcoidosis listed for
lung transplantation, and to create a model for predicting intermediate-term mortality in these …

Sarcoidosis, a granulomatous disorder of unknown etiology, characteristically involves
multiple organs. However, pulmonary manifestations typically dominate. Chest radiographs …

Rationale Pulmonary hypertension is a known complication of sarcoidosis and is associated
with increased mortality. Little is known about the outcome of sarcoidosis-associated …

Background Pulmonary hypertension (PH) is a common complication of sarcoidosis that is
associated with increased mortality. The pathogenesis of PH in sarcoidosis is uncertain, and …